Globe Life (NYSE:GL) CMO Jennifer Allison Haworth Sells 10,000 Shares

Globe Life Inc. (NYSE:GL) CMO Jennifer Allison Haworth sold 10,000 shares of the business’s stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $143.14, for a total transaction of $1,431,400.00. Following the transaction, the chief marketing officer owned 17,479 shares in the company, valued at $2,501,944.06. The trade was a 36.39% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Globe Life Price Performance

GL stock traded up $0.36 during mid-day trading on Friday, reaching $144.46. The company’s stock had a trading volume of 470,467 shares, compared to its average volume of 530,026. The stock has a market cap of $11.50 billion, a PE ratio of 10.26 and a beta of 0.47. The company’s 50 day moving average is $140.30 and its two-hundred day moving average is $138.37. Globe Life Inc. has a fifty-two week low of $109.38 and a fifty-two week high of $152.71. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.41.

Globe Life (NYSE:GL) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). The company had revenue of $1.52 billion during the quarter, compared to analysts’ expectations of $1.53 billion. Globe Life had a net margin of 19.37% and a return on equity of 21.75%. Globe Life’s revenue for the quarter was up 3.6% on a year-over-year basis. During the same quarter last year, the company earned $3.14 earnings per share. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Equities research analysts expect that Globe Life Inc. will post 13.87 EPS for the current year.

Analysts Set New Price Targets

GL has been the topic of a number of analyst reports. Wells Fargo & Company reduced their target price on shares of Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a research note on Friday, October 24th. Weiss Ratings downgraded Globe Life from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Wednesday, January 14th. Keefe, Bruyette & Woods raised their price objective on Globe Life from $160.00 to $162.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 28th. JPMorgan Chase & Co. increased their target price on shares of Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Finally, Evercore downgraded shares of Globe Life from an “outperform” rating to an “in-line” rating and set a $155.00 price target on the stock. in a research note on Tuesday, January 6th. Seven analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $171.00.

Institutional Trading of Globe Life

Hedge funds have recently modified their holdings of the stock. Mather Group LLC. purchased a new stake in Globe Life during the third quarter worth approximately $28,000. Hilton Head Capital Partners LLC purchased a new stake in shares of Globe Life in the 4th quarter valued at about $30,000. CYBER HORNET ETFs LLC acquired a new stake in shares of Globe Life in the 2nd quarter valued at about $28,000. Assetmark Inc. grew its stake in Globe Life by 777.8% during the 2nd quarter. Assetmark Inc. now owns 237 shares of the company’s stock worth $29,000 after buying an additional 210 shares during the last quarter. Finally, MUFG Securities EMEA plc acquired a new position in Globe Life during the second quarter worth approximately $31,000. 81.61% of the stock is currently owned by institutional investors and hedge funds.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.